Schillinger Martin, Exner Markus, Mlekusch Wolfgang, Haumer Markus, Rumpold Helmut, Ahmadi Ramazanali, Sabeti Schila, Wagner Oswald, Minar Erich
Department of Angiology, University of Vienna Medical School, Währinger Gürtel 18-20, Austria.
Radiology. 2003 May;227(2):419-25. doi: 10.1148/radiol.2272020137. Epub 2003 Mar 20.
To determine the association between pre- and postintervention serum C-reactive protein (CRP) levels and 6-month restenosis after endovascular treatment of atherosclerotic lesions in arteries below the knee.
Eighty-nine patients with peripheral arterial disease underwent primary successful percutaneous transluminal angioplasty (PTA) of the distal popliteal, anterior tibial, posterior tibial, and fibular arteries. Six-month patency was evaluated with the ankle brachial index (ABI) and color-coded duplex ultrasonography (US). The association between restenosis and preintervention and 48-hour postintervention CRP levels was assessed with multiple logistic regression analysis.
ABI improved from a preintervention median of 0.54 to a postintervention median of 0.75 (P <.001). The primary technical success rate was 94% (100 of 106). In 50 patients, a suboptimal technical result was achieved with 30%-40% residual stenosis at the dilated segment. The median ABI at 6 months was 0.65, and it was inversely correlated with preintervention (r = -0.27, P =.009) and 48-hour postintervention (r = -0.40, P <.001) CRP levels. With duplex US at 6 months, restenosis (> or =50%) occurred in 36 patients. Patients with a preintervention CRP level of 0.23-0.92 mg/dL (2.3-9.2 mg/L) had a 3.7-fold increased adjusted risk for restenosis (P =.05); patients with a preintervention CRP level greater than 0.92 mg/dL (9.2 mg/L) had a 4.7-fold increased adjusted risk (P =.03). Postintervention CRP values greater than 2.42 mg/dL (24.2 mg/L) were associated with a 10.7-fold adjusted risk for restenosis (P =.002). Suboptimal PTA result was the only other parameter associated with an increased risk for restenosis (odds ratio, 3.7; P =.03).
Pre- and postintervention CRP levels were associated with restenosis after PTA of the distal popliteal and tibioperoneal arteries, which indicates that inflammation plays a crucial role in the pathophysiology of this process.
确定膝下动脉粥样硬化病变血管腔内治疗前后血清C反应蛋白(CRP)水平与6个月再狭窄之间的关联。
89例外周动脉疾病患者成功接受了腘动脉远端、胫前动脉、胫后动脉和腓动脉的初次经皮腔内血管成形术(PTA)。采用踝肱指数(ABI)和彩色编码双功超声(US)评估6个月通畅情况。通过多因素逻辑回归分析评估再狭窄与干预前及干预后48小时CRP水平之间的关联。
ABI从干预前的中位数0.54提高到干预后的中位数0.75(P <.001)。主要技术成功率为94%(106例中的100例)。50例患者扩张段残余狭窄30%-40%,技术结果欠佳。6个月时ABI中位数为0.65,与干预前(r = -0.27,P =.009)和干预后48小时(r = -0.40,P <.001)的CRP水平呈负相关。6个月时采用双功超声检查,36例患者出现再狭窄(≥50%)。干预前CRP水平为0.23-0.92 mg/dL(2.3-9.2 mg/L)的患者再狭窄校正风险增加3.7倍(P =.05);干预前CRP水平大于0.92 mg/dL(9.2 mg/L)的患者再狭窄校正风险增加4.7倍(P =.03)。干预后CRP值大于2.42 mg/dL(24.2 mg/L)与再狭窄校正风险增加10.7倍相关(P =.002)。PTA结果欠佳是与再狭窄风险增加相关的唯一其他参数(比值比,3.7;P =.03)。
干预前后CRP水平与腘动脉远端和胫腓动脉PTA后的再狭窄相关,这表明炎症在该过程的病理生理中起关键作用。